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Purpose.  —  To  determine  whether  pupil  dilation  affects  biometric  measurements  and  intraoc-
ular lens  (IOL)  power  calculation  made  using  the  new  swept-source  optical  coherence
tomography-based  optical  biometer  (IOLMaster  700©;  Carl  Zeiss  Meditec,  Jena,  Germany).
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Procedures.  —  Eighty-one  eyes  of  81  patients  evaluated  for  cataract  surgery  were  prospectively
examined  using  the  IOLMaster  700© before  and  after  pupil  dilation  with  tropicamide  1%.  The
measurements  made  were:  axial  length  (AL),  central  corneal  thickness  (CCT),  aqueous  chamber
depth (ACD),  lens  thickness  (LT),  mean  keratometry  (MK),  white-to-white  distance  (WTW)  and
pupil diameter  (PD).  Holladay  II  and  SRK/T  formulas  were  used  to  calculate  IOL  power.  Agree-
ment between  measurement  modes  (with  and  without  dilation)  was  assessed  through  intraclass
correlation  coefﬁcients  (ICC)  and  Bland-Altman  plots.
Results.  —  Mean  patient  age  was  75.17  ±  7.54  years  (range:  57—92).  Of  the  variables  deter-
mined, CCT,  ACD,  LT  and  WTW  varied  signiﬁcantly  according  to  pupil  dilation.  Excellent
intraobserver  correlation  was  observed  between  measurements  made  before  and  after  pupil
dilation.  Mean  IOL  power  calculation  using  the  Holladay  2  and  SRK/T  formulas  were  unmodiﬁed
by pupil  dilation.
Conclusions.  —  The  use  of  pupil  dilation  produces  statistical  yet  not  clinically  signiﬁcant  dif-
ferences  in  some  IOLMaster  700© measurements.  However,  it  does  not  affect  mean  IOL  power
calculation.
© 2016  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Propos.  —  Déterminer  si  la  dilatation  pupillaire  modiﬁe  les  mesures  biométriques  et  le  calcul  de
la puissance  de  l’implant  intraoculaire  obtenus  avec  un  nouveau  biomètre  optique  basé  sur  la
tomographie  par  cohérence  optique  swept-source  (IOLMaster  700© ;  Carl  Zeiss  Meditec,  Jena,
Allemagne)
Méthodes. —  Nous  avons  évalué  prospectivement  81  yeux  de  81  patients  prévus  pour  la  chirurgie
de la  cataracte  au  moyen  du  biomètre  IOLMaster  700©,  avant  et  après  dilatation  pupillaire  avec
tropicamide  1  %.  Les  mesures  réalisées  ont  été  :  longueur  axiale  (AL),  épaisseur  cornéenne
centrale  (CCT),  profondeur  de  la  chambre  antérieure  (épaisseur  cornéenne  exclue)  (ACD),
épaisseur  cristallinienne  (LT),  kératométrie  moyenne  (MK),  distance  blanc  à  blanc  (WTW)  et
diamètre pupillaire  (PD).  Les  formules  Holladay  II  et  SRK/T  ont  été  employées  pour  calculer  la
puissance de  l’implant  intraoculaire.  Nous  avons  évalué  la  concordance  entre  les  deux  méth-
odes de  mesure  (sous  dilatation  pupillaire  et  sans)  au  moyen  des  coefﬁcients  de  corrélation
intraclasse  (ICC)  et  des  graphiques  de  Bland-Altman.
Résultats.  — La  moyenne  d’âge  des  patients  était  de  75,17  ±  7,54  ans  (intervalle  :  57—92).  Parmi
les variables  mesurées,  la  CCT,  l’ACD,  la  LT  et  la  WTW  montraient  des  variations  signiﬁcatives  en
fonction de  la  dilatation  pupillaire.  On  a  observé  une  excellente  corrélation  intra-observateur
entre les  mesures  réalisées  avant  et  après  la  dilatation  pupillaire.  Celle-ci  ne  modiﬁait  pas  la
prédiction  de  la  puissance  moyenne  de  l’implant  avec  Holladay  2  et  SKR/T.
Conclusions.  —  L’emploi  de  tropicamide  1  %  produit  des  différences  signiﬁcatives  du  point  de  vue
statistique mais  pas  clinique  sur  certaines  mesures  réalisées  avec  IOLMaster  700©. Cependant,
la mesure  de  la  puissance  moyenne  de  l’implant  intraoculaire  n’est  pas  affectée.
© 2016  Elsevier  Masson  SAS.  Tous  droits  re´serve´s.
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he  success  of  cataract  surgery  depends  on  many  factors,
ne  of  the  most  important  being  accurate  calculation  of
ntraocular  lens  (IOL)  power  [1].  Three  main  measurements
re  used  for  IOL  calculation:  axial  length  (AL),  anterior
hamber  depth  (ACD)  and  corneal  power.  In  addition,  some
ourth  generation  formulas  such  as  Holladay  2,  also  requires
ens  thickness  (LT)  and  white-to-white  distance  (WTW).  ALPlease  cite  this  article  in  press  as:  Arriola-Villalobos  P,  et  al.  E
and  iol  power  calculation  made  using  the  new  swept-source  op
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nd  ACD  are  normally  determined  through  ultrasound  or
ptical  biometry.  Currently  used  optical  methods  include
he  IOLMaster  500© (Carl  Zeiss  Meditec  AG,  Jena,  Germany)
l
v
lased  on  partial  coherence  interferometry,  the  LENSTAR
00© (Haag-Streit  AG,  Koeniz,  Switzerland),  which  uses
ptical  low-coherence  reﬂectometry  (OLCR)  powered  by  a
uperluminescent  diode  (SLD)  and  the  newly  developed  IOL-
aster  700© (Carl  Zeiss  Meditec  AG,  Jena,  Germany)  based
n  Swept  Source  optical  coherence  tomography  (SS-OCT)
echnology.  For  more  than  15  years,  the  IOLMaster  500©
as  been  the  benchmark  for  optical  biometry  measure-
ents,  offering  high  precision  and  good  resolution  for  axialffect  of  pharmacological  pupil  dilation  on  measurements
tical  coherence  tomography-based  optical  biometer.  J  Fr
3
ength  (AL),  anterior  chamber  depth  (ACD)  and  corneal  cur-
ature  [2].  Moreover,  the  LENSTAR©,  which  also  measures
ens  thickness  (LT)  and  central  corneal  thickness  (CCT),  has
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AL  was  within  0.33  mm  in  all  eyes  and  within  0.10  mm  in  77
eyes  (95.06%);  and  MK  was  within  0.5D  in  77  eyes  (95.06%)
and  within  1D  in  80  eyes  (98.76%).  Finally,  IOL  powers
Table  1  IOLMaster  700© measurements  (means  ±  SD)
made  before  and  after  pupil  dilation.
Variable  No  dilation  Dilation
AL/mm  23.526  ±  1.66  23.523  ±  1.66
CCT/m  544.06  ±  35.92  546.47  ±  35.94
ACD/mm  2.531  ±  0.38  2.58  ±  0.39
LT/mm 4.717  ±  0.42  4.706  ±  0.42
[K]/D  44.351  ±  1.52 44.344  ±  1.51
WTW/mm  11.847  ±  0.39  11.879  ±  0.4
PD/mm  3.765  ±  0.91 6.458  ±  0.73
AL: axial length; CCT: central corneal thickness; ACD: anteriorARTICLEJFO-1521; No. of Pages 7
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shown  good  reproducibility  [3]  and  good  correlation  with
the  IOLMaster  500© [4].  The  new  IOLMaster  700©, the  ﬁrst
SS-OCT-based  biometer,  has  so  far  shown  excellent  repeat-
ability  and  reproducibility,  along  with  very  high  agreement
with  the  IOLMaster  500© [5].
The  effects  of  pupil  dilation  on  optical  biometry  measure-
ments  have  been  fairly  well  established.  Thus  according  to
several  reports,  pharmacological  mydriasis  does  not  seem  to
signiﬁcantly  affect  IOLmaster  500© measurements  and  IOL
predictions  [6—8]  and  similar  results  have  been  reported  for
LENSTAR© [9,10].
To  the  best  of  our  knowledge,  no  studies  have  hitherto
studied  the  effect  of  pupil  dilation  on  the  accuracy  of  IOL-
Master  700© measurements.
The  purpose  of  the  current  study  was  to  determine
the  inﬂuence  of  pharmacological  pupil  dilation  on  mea-
surements  using  the  new  IOLMaster  700©.  To  determine
the  clinical  signiﬁcance  of  possible  differences  in  measure-
ments,  we  also  calculated  IOL  powers.
Patients and methods
The  subjects  for  this  randomized  diagnostic  technology  eval-
uation  study  were  consecutively  recruited  among  patients
scheduled  for  cataract  surgery  at  our  department.  The
inclusion  criterion  was  age-related  cataract  (including  mild
cataract).  Exclusion  criteria  were  prior  eye  surgery,  an
active  ocular  pathology  such  as  uveitis  or  retinal  degen-
eration  and  inability  to  ﬁxate  because  of  an  eye  disease
and  prior  contact  lens  use.  When  both  eyes  met  these
criteria,  only  the  right  eye  was  included  into  the  study,
because  measurements  will  be  more  similar  between  fel-
low  eyes  than  individuals  [11].  The  study  protocol  adhered
to  the  tenets  of  the  Declaration  of  Helsinki  and  Spanish
legislation  and  was  approved  by  our  Institutional  Clinical
Research  Ethics  Committee.  Before  recruitment,  written
legally-binding  informed  consent  was  obtained  from  each
patient.
After  a  brief  biomicroscopy  examination  without  instil-
lation  of  drops  to  conﬁrm  the  diagnosis  of  cataract,
non-contact  biometric  measurements  were  obtained  in  all
participants  using  the  IOLMaster  700©.  Subjects  were  tested
between  8  am  and  3  pm  in  a  small,  diffusely  lit  ofﬁce  which
was  centrally  heated  to  a  temperature  of  21 ◦C  to  25 ◦C.
There  were  no  ventilation  ducts  over  the  equipment.  Sub-
jects  were  asked  to  blink  just  before  measurements  so  that
the  tear  ﬁlm  over  the  cornea  would  be  optically  smooth.
IOLMaster  700© measurements  were  only  accepted  when  val-
idated  by  the  device’s  inbuilt  quality  test.  The  data  recorded
were  AL,  CCT,  ACD  (aqueous  chamber  depth,  measured  as
endothelium  to  lens  distance),  LT,  mean  keratometry  (MK),
WTW  and  pupil  diameter  (PD).  Next,  all  patients  under-
went  a  full  ophthalmic  examination  including  Snellen  visual
acuity,  complete  slit-lamp  biomicroscopy  and  Goldmann
applanation  tonometry.  The  pupil  was  then  dilated  using
tropicamide  1%  (Tropicamida,  Alcon  Cusi,  Barcelona,  Spain)
and  a  fundus  examination  performed.  After  fundoscopy,  thePlease  cite  this  article  in  press  as:  Arriola-Villalobos  P,  et  al.  E
and  iol  power  calculation  made  using  the  new  swept-source  op
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patients  were  once  again  subjected  to  the  same  IOLMas-
ter  700© procedure  as  before  dilation  and  the  same  data
were  recorded.  Both  examinations  were  performed  for  each
participant  by  the  same  examiner. PRESS
ion  with  IOLMaster700  3
The  IOL  power  required  for  emmetropia  using  an  A-
onstant  of  118.0  with  the  Holladay  2  and  SRK/T  IOL
ormulas  was  calculated  after  the  examination.
For  a  descriptive  statistical  analysis,  we  used  Excel
011  (Microsoft  Corp.  Redmond,  WA,  USA)  with  SPSS  soft-
are  (version  18.0,  SPSS  Inc.).  Results  are  shown  as
ean  ±  standard  deviation  (SD).  Signiﬁcance  was  set  at
≤0.05.  Data  were  compared  using  a  paired-sample  t  test.
onsistency  between  pre-  and  post  dilation  measurements
as  assessed  through  intraclass  correlation  coefﬁcients
ICC)  at  the  95%  conﬁdence  level.  Bland-Altman  plots  were
lso  constructed  to  compare  the  two  sets  of  measurements
12]. We  also  calculated  proportions  of  main  measurement
ifferences  falling  within  the  clinically  acceptable  ranges
eﬁned  by  Jasvinder  et  al.  [13]: IOL  power  within  1 diopter
D),  1D  to  2D  or  more  than  2D;  AL  within  0.33  mm  or
.10  mm;  and  MK  within  1D  or  0.5D.  Ninety-ﬁve  percent  lim-
ts  of  agreement  for  each  measurement  were  computed  as
he  mean  ±  2  SD  of  the  difference  between  pre-  and  post
ilation  values.
esults
he  study  sample  was  comprised  of  81  eyes  of  81  patients
52  women)  of  mean  age  75.17  ±  7.54  years  (range:  57—92).
n  71  (86.6%)  participants,  the  eye  examined  was  the  right
ye.
Of  the  data  determined  (Table  1),  CCT,  ACD,  LT  and
TW  differed  signiﬁcantly  before  and  after  pupil  dila-
ion  (Table  2).  Good  correlation  was  indicated  by  the  ICC
Table  2)  for  all  the  variables.  The  IOL  power  prediction
ata  are  provided  in  Table  3. No  statistical  differences  were
etected  in  IOL  power  predictions  based  on  pre-  and  post
ilation  measurements  (Table  4).  Agreement  between  both
OL  formulas  was  excellent.
The  Bland-Altman  plots  illustrate  post  dilation  mea-
urement  differences  and  the  differences  in  IOL  power
alculated  using  both  formulas  (Fig.  1),  along  with  the  95%
oA.
Measurement  differences  were  all  clinically  acceptable:ffect  of  pharmacological  pupil  dilation  on  measurements
tical  coherence  tomography-based  optical  biometer.  J  Fr
3
chamber depth; LT: lens thickness; [K]: mean keratometry; D:
diopters; WTW: white-to-white distance; PD: pupil diameter.
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Table  2 Agreement  between  measurements  made  before  and  after  pupil  dilation.
Variable  Mean  difference  P  ICC  CI  (95%)  95%  LoA
Lower  Upper
AL/mm  0.0032  ±  0.034  0.398  1  1—1  −0.0648  0.0712
CCT/m  −2.407  ±  8.84  0.016  0.968  0.951—0.979  −20.087  15.273
ACD/mm  −0.048  ±  0.031  <  0.001  0.989  0.983—0.993  −0.11  0.014
LT/mm  0.0109  ±  0.018  <  0.001  0.999  0.998—0.999  −0.0251  0.0469
MK/D  0.0075  ±  0.223  0.762  0.989  0.983—0.993  −0.4385  0.4535
WTW/mm  −0.032  ±  0.115  0.014  0.956  0.932—0.971  −0.262  0.1471
ICC: intraclass correlation coefﬁcient; CI: conﬁdence interval; LoA: limits of agreement; AL: axial length; CCT: central corneal thickness;
ACD: endothelium to lens distance; LT: lens thickness; MK: mean keratometry; WTW: white-to-white distance.
Table  3  Mean  of  IOL  power  predictions  (in  diopters)
before  and  after  pupil  dilation.
Formula  No  dilation  Dilation
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iHolladay  2  19.07  ±  4.49  19.05  ±  4.45
SRK/T  19.27  ±  4.51  19.29  ±  4.49
alculated  with  the  SRK/T  formula  were  all  within  1D,  while
nly  in  four  eyes  (4.94%)  predicted  lens  power  using  the
olladay  2  formula  differed  by  1D  to  2D.
iscussion
he  results  of  our  study  indicate  that  pupil  dilation  affect
ome  IOLMaster  700© measurements.  Given  the  established
xcellent  intraobserver  repeatability  of  the  IOLMaster  700©
5],  we  can  assume  that  the  differences  observed  were
ttributable  to  pupil  dilation.  Notwithstanding,  these  statis-
ical  differences  were  clinically  insigniﬁcant  since  IOL  power
redictions  were  unaffected.  Only  in  four  IOL  power  pre-
ictions  (with  the  Holladay  2  formula)  did  the  difference
xceed  1D.  In  addition,  there  was  excellent  agreement  in
ll  measurements  before  and  after  pupil  dilation  and  ICCs
ere  higher  than  0.95  for  all  variables.
In  three  studies  examining  the  effect  of  pupil  dilation
n  IOLMaster  500© measurements  [6—8],  no  effects  were
bserved  on  AL  and  only  one  study  reported  a  signiﬁcant  dif-Please  cite  this  article  in  press  as:  Arriola-Villalobos  P,  et  al.  E
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erence  in  pre-  and  post  dilation  MK  data  [6].  In  addition,  in
he  only  one  study  in  which  the  ACD  was  measured,  this  vari-
ble  was  found  to  increase  after  pupil  dilation.  Two  furthers
tudies  have  also  addressed  the  inﬂuence  of  pupil  dilation
i
p
E
c
Table  4 Agreement  between  predicted  IOL  power  (in  diopte
dilation.
Formula  Mean  difference  P  ICC
Holladay  2  0.0181  ±  0.456  0.721  0.9
SRK/T  −0.0151  ±  0.273  0.618  0.9
ICC: intraclass correlation coefﬁcient; CI: conﬁdence interval; LoA: limn  the  accuracy  of  LENSTAR© measurements  [9,10].  These
nvestigations  detected  no  signiﬁcant  differences  in  AL  or
K  data,  whereas  both  studies  found  that  ACD  was  signiﬁ-
antly  greater  in  response  to  pupil  dilation.  Other  variables,
uch  as  LT,  CCT  or  WTW,  were  not  signiﬁcantly  modiﬁed  after
upil  dilation  [10].
The  ﬁndings  of  the  present  study  are  fairly  consistent
ith  data  on  the  effects  of  pupil  dilation  reported  for  other
ptical  biometry  devices.  Thus,  no  signiﬁcant  change  in  AL
s  produced  in  response  to  pupil  dilation  using  both  the
OLMaster  500© and  LENSTAR© [6—10].  The  slight,  though
igniﬁcant,  increase  in  CCT  observed  in  our  study  is  consis-
ent  with  the  ﬁndings  of  other  authors,  who  noted  signiﬁcant
ncreases  in  CCT  after  pupil  dilation  with  tropicamide  eye
rops  [14,15].  No  clear  cause  was  identiﬁed  for  this  effect.
 deeper  anterior  chamber  after  pupil  dilation  has  been
escribed  for  the  IOLMaster  500© [8]  and  LENSTAR© [9,10].
his  deeping  of  the  anterior  chamber  seems  to  be  sec-
ndary  to  a  widening  of  the  anterior  chamber  angle,  as
eported  previously  in  one  study  which  evaluated  the  effect
f  tropicamide  1%  on  anterior  segment  geometry  with  ultra-
ound  biomicroscopy  [16].  Signiﬁcant  LT  changes  have  been
ttributed  to  accommodation  [17],  but  not  to  the  use  of
ropicamide  1%  [16]. The  cause  of  the  thinner  LT  after  pupil
ilation  found  in  the  present  study  is  unknown,  but  maybe
econdary  to  the  rearward  movement  of  the  iris  plane  due
o  the  anterior  chamber  angle  widening.  Although,  the  sig-
iﬁcant  decrease  in  LT  of  11  microns  observed  in  our  study
s  clinically  insigniﬁcant.  In  the  only  study  in  which  a  changeffect  of  pharmacological  pupil  dilation  on  measurements
tical  coherence  tomography-based  optical  biometer.  J  Fr
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n  MK  measured  by  optical  biometry  was  detected  after
upil  dilation,  the  authors  attributed  this  to  chance  [6].
ffectively,  other  optical  biometry  studies  have  revealed  no
hange  in  corneal  curvature  after  pupil  dilation  [7—10]  and
rs)  based  on  measurements  made  before  and  after  pupil
 CI  (95%)  95%  LoA
Lower  Upper
95  0.992—0.997  −0.8939  0.9301
98  0.997—0.999  −0.561  0.531
its of agreement.
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Figure 1. Bland-Altman plots showing agreement between measurements taken with the IOLmaster 700© before and after pharmacological
pupil dilation. The middle line shows the mean difference and the bottom and top lines indicate the lower and upper 95% limits of agreement,
respectively. A: AL measurements; B: CCT measurements; C: ACD measurements; D: LT measurements; E: MK measurements; F: WTW
measurements; G: IOL power calculated with the Holladay 2 formula, and H: IOL power calculated with the SRK/T formula. (AL: axial
length; CCT: central corneal thickness; ACD: endothelium to lens distance; LT: lens thickness; MK: mean keratometry; D: diopters; WTW:
white-to-white distance; PD: pupil diameter; IOL: intraocular lens).Please  cite  this  article  in  press  as:  Arriola-Villalobos  P,  et  al.  E
and  iol  power  calculation  made  using  the  new  swept-source  op
Ophtalmol  (2016),  http://dx.doi.org/10.1016/j.jfo.2016.09.00ffect  of  pharmacological  pupil  dilation  on  measurements
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his  lack  of  effect  was  also  reported  for  two  different  corneal
opography  systems  [15,18].  In  our  study,  a  slight  but  signif-
cant  increase  after  pupil  dilation  was  also  produced  in  the
TW  distance.  We  attribute  this  to  the  variability  of  the
easurement  process  itself.
Excellent  agreement  was  detected  here  between  pre-
nd  post  dilation  measurements,  with  similar  results  to
hose  observed  in  interoperator  repeatability  measurements
5].
The  accurate  determination  of  AL  and  MK  is  crucial  for  IOL
ower  calculation  [19].  For  this  purpose,  most  ophthalmol-
gists  use  third-generation  IOL  formulas,  and  the  SRK/T  [20]
s  probably  the  most  widely  used  today  for  IOL  prediction.
his  formula  uses  AL  and  corneal  curvature  to  estimate  the
ffective  lens  position  (ELP).  Thus,  errors  in  AL  or  MK  may
asily  give  rise  to  unexpected  refractive  errors.  Our  results
ndicate  that  pupil  dilation  does  not  signiﬁcantly  affect
RK/T  IOL  calculation  using  the  IOLMaster  700©.  This  was
xpected  because  of  the  high  agreement  between  pre-  and
ost  dilation  AL  and  MK  measurements  observed.  In  addi-
ion,  predicted  IOL  power  calculated  with  the  SRK/T  formula
as  within  1D  in  all  eyes  and  within  0.5D  to  1D  in  only  ﬁve
yes  (6.17%)  (Fig.  1).  Worst  agreement  was  reported  for  the
OLMaster  500© [6]  in  that  predicted  IOL  power  varied  by
.5D  to  1D  in  12%  of  eyes  and  was  within  1D  and  2D  in  4%
fter  pupil  dilation.  Similarly,  9.1%  of  the  eyes  in  one  of
he  LENSTAR© studies  [9]  showed  differences  in  IOL  power
alculated  with  the  SRK/T  formula  from  0.5D  to  1D.  How-
ver,  in  the  other  report  [10],  results  were  similar  to  those
f  the  present  study,  in  which  no  eyes  showed  a  calculated
OL  power  difference  above  1D  and  only  6.94%  of  the  eyes
eturned  a  power  calculation  within  0.5D  to  1D  using  the
RK/T  IOL  formula.
The  newer  fourth-generation  IOL  formulas  such  as  Holla-
ay  2  [21]  or  Olsen  et  al.  [22],  besides  AL  and  MK,  consider
ther  variables  provided  by  the  IOLMaster  700©,  like  ACD
epithelium  to  lens  distance),  LT  and  WTW,  for  ELP  esti-
ation.  We  observed  signiﬁcant  differences  in  these  three
ariables  after  pupil  dilation.  Despite  this,  mean  IOL  power
alculated  with  the  Holladay  2  formula  was  signiﬁcantly
naffected  by  pupil  dilation,  with  the  exception  of  four  eyes
4.94%),  which  showed  a  difference  of  1D  to  2D,  and  22
yes  (27.16%)  with  a  value  within  0.5D  to  1D.  These  results
re  quite  different  to  those  obtained  with  the  SRK/T  for-
ula  based  only  in  two  ocular  measurements,  which  did  not
hange  signiﬁcantly  with  pupil  dilation.  In  contrast,  signiﬁ-
ant  effects  of  dilation  were  produced  on  some  of  the  other
cular  variables  included  in  the  Holladay  2  IOL  formula.
lthough  the  difference  in  mean  theoretical  IOL  power  was
maller  than  0.02D,  this  could  have  affected  the  IOL  chosen
or  implantation  in  almost  one  third  of  patients.  The  real
mpact  on  ﬁnal  refractive  error  after  cataract  surgery  would,
evertheless,  be  small.  The  effects  of  pupil  dilatation  on
OL  power  predictions  using  the  Holladay  2  formula  for  the
OLMaster  500© have  not  been  examined.  In  one  such  study
or  LENSTAR© [10],  8.33%  of  the  eyes  showed  predicted  lens
ower  with  differences  higher  than  0.5D  after  pupil  dilation.
There  are  some  limitations  to  our  study.  First  of  all,  ourPlease  cite  this  article  in  press  as:  Arriola-Villalobos  P,  et  al.  E
and  iol  power  calculation  made  using  the  new  swept-source  op
Ophtalmol  (2016),  http://dx.doi.org/10.1016/j.jfo.2016.09.00
ample  did  not  include  short  eyes  (<  21.5  mm)  for  which
ifferent  results  might  be  expected.  In  addition,  patients
ith  active  ocular  diseases  as  well  as  macular  diseases  were
xcluded,  so  results  are  not  representative  of  all  cataract PRESS
P.  Arriola-Villalobos  et  al.
atients.  Finally,  the  lack  of  repeatability  tests  and  a  control
roup  could  be  a  drawback,  though  the  repeatability  of  IOL-
aster  700© measurements  has  been  shown  to  be  excellent
5].
The  participants  of  this  study  were  recruited  from  a  con-
inuous  cohort.  As  inclusion  criteria  were  not  strict,  they
epresent,  as  far  as  possible,  patients  examined  in  routine
linical  practice.  Thus,  we  did  not  restrict  comparisons  to
atients  with  the  same  degree  of  cataract  severity  or  adjust
or  potential  effects  of  age  or  gender.
In  conclusion,  given  the  need  for  pharmacological  pupil
ilation  in  any  preoperative  ophthalmic  examination,  the
ffects  of  this  factor  on  measurements  made  using  an  opti-
al  biometry  device  need  to  be  well  established.  Our  ﬁnding
ndicate  we  can  expect  no  signiﬁcant  impact  of  pupil  dilation
n  IOL  power  predictions  based  on  IOLMaster  700© measure-
ents.
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